Diversifying selection in human papillomavirus type 16 lineages based on complete genome analyses - PubMed (original) (raw)
Diversifying selection in human papillomavirus type 16 lineages based on complete genome analyses
Zigui Chen et al. J Virol. 2005 Jun.
Abstract
Human papillomavirus type 16 (HPV16) is the primary etiological agent of cervical cancer, the second most common cancer in women worldwide. Complete genomes of 12 isolates representing the major lineages of HPV16 were cloned and sequenced from cervicovaginal cells. The sequence variations within the open reading frames (ORFs) and noncoding regions were identified and compared with the HPV16R reference sequence. This whole-genome approach gives us unprecedented precision in detailing sequence-level changes that are under selection on a whole-viral-genome scale. Of 7,908 base pair nucleotide positions, 313 (4.0%) were variable. Within the 2,452 amino acids (aa) comprising 8 ORFs, 243 (9.9%) amino acid positions were variable. In order to investigate the molecular evolution of HPV16 variants, maximum likelihood models of codon substitution were used to identify lineages and amino acid sites under selective pressure. Five codon sites in the E5 (aa 48, 65) and E6 (aa 10, 14, 83) ORFs were demonstrated to be under diversifying selective pressure. The E5 ORF had the overall highest nonsynonymous/synonymous substitution rate (omega) ratio (M3 = 0.7965). The E2 gene had the next-highest omega ratio (M3 = 0.5611); however, no specific codons were under positive selection. These data indicate that the E6 and E5 ORFs are evolving under positive Darwinian selection and have done so in a relatively short time period. Whether response to selective pressure upon the E5 and E6 ORFs contributes to the biological success of HPV16, its specific biological niche, and/or its oncogenic potential remains to be established.
Figures
FIG. 1.
Phylogenetic trees inferred from the complete genomes of representative HPV16 variants. Trees were generated using multiple algorithms. (A) Tree created using Bayesian construction and MP based on the nucleotide sequences of the eight ORFs and the URR. (B) Tree created using Bayesian construction and ML based on the nucleotide sequences of the eight ORFs and the URR. (C) Tree created using Bayesian construction and MP based on the amino acid sequences of the eight ORFs. The parsimony tree based on the concatenated amino acid and nucleotide sequences was similar to the tree shown in panel C (data not shown). The numbers on or near branches are support indices for the algorithms described for each tree.
Similar articles
- Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2, and L1 coding segments.
Yamada T, Wheeler CM, Halpern AL, Stewart AC, Hildesheim A, Jenison SA. Yamada T, et al. J Virol. 1995 Dec;69(12):7743-53. doi: 10.1128/JVI.69.12.7743-7753.1995. J Virol. 1995. PMID: 7494284 Free PMC article. - Evolutionary dynamics of variant genomes of human papillomavirus types 18, 45, and 97.
Chen Z, DeSalle R, Schiffman M, Herrero R, Burk RD. Chen Z, et al. J Virol. 2009 Feb;83(3):1443-55. doi: 10.1128/JVI.02068-08. Epub 2008 Nov 26. J Virol. 2009. PMID: 19036820 Free PMC article. - Genus specific features of bovine papillomavirus E6, E7, E5 and E8 proteins.
Tomita Y, Ogawa T, Jin Z, Shirasawa H. Tomita Y, et al. Virus Res. 2007 Mar;124(1-2):231-6. doi: 10.1016/j.virusres.2006.10.006. Epub 2006 Nov 28. Virus Res. 2007. PMID: 17126443 - Animal papillomaviruses.
Rector A, Van Ranst M. Rector A, et al. Virology. 2013 Oct;445(1-2):213-23. doi: 10.1016/j.virol.2013.05.007. Epub 2013 May 25. Virology. 2013. PMID: 23711385 Review. - Primer-directed sequencing of human papillomavirus types.
Delius H, Hofmann B. Delius H, et al. Curr Top Microbiol Immunol. 1994;186:13-31. doi: 10.1007/978-3-642-78487-3_2. Curr Top Microbiol Immunol. 1994. PMID: 8205838 Review. No abstract available.
Cited by
- Phylogeny and evolution of papillomaviruses based on the E1 and E2 proteins.
Bravo IG, Alonso A. Bravo IG, et al. Virus Genes. 2007 Jun;34(3):249-62. doi: 10.1007/s11262-006-0017-4. Epub 2006 Aug 22. Virus Genes. 2007. PMID: 16927128 - Sequence imputation of HPV16 genomes for genetic association studies.
Smith B, Chen Z, Reimers L, van Doorslaer K, Schiffman M, Desalle R, Herrero R, Yu K, Wacholder S, Wang T, Burk RD. Smith B, et al. PLoS One. 2011;6(6):e21375. doi: 10.1371/journal.pone.0021375. Epub 2011 Jun 23. PLoS One. 2011. PMID: 21731721 Free PMC article. - HPV types and variants among cervical cancer tumors in three regions of Tunisia.
KrennHrubec K, Mrad K, Sriha B, Ben Ayed F, Bottalico DM, Ostolaza J, Smith B, Tchaikovska T, Soliman AS, Burk RD. KrennHrubec K, et al. J Med Virol. 2011 Apr;83(4):651-7. doi: 10.1002/jmv.22011. J Med Virol. 2011. PMID: 21328380 Free PMC article. - Cross-protection of the Bivalent Human Papillomavirus (HPV) Vaccine Against Variants of Genetically Related High-Risk HPV Infections.
Harari A, Chen Z, Rodríguez AC, Hildesheim A, Porras C, Herrero R, Wacholder S, Panagiotou OA, Befano B, Burk RD, Schiffman M; Costa Rica HPV Vaccine Trial Group. Harari A, et al. J Infect Dis. 2016 Mar 15;213(6):939-47. doi: 10.1093/infdis/jiv519. Epub 2015 Oct 30. J Infect Dis. 2016. PMID: 26518044 Free PMC article. Clinical Trial. - Sequence variation in the E2-binding domain of HPV16 and biological function evaluation in Tunisian cervical cancers.
Kahla S, Kochbati L, Hammami S, Chanoufi MB, Maalej M, Oueslati R. Kahla S, et al. Biomed Res Int. 2014;2014:639321. doi: 10.1155/2014/639321. Epub 2014 Jun 17. Biomed Res Int. 2014. PMID: 25032221 Free PMC article.
References
- Anisimova, M., J. P. Bielawski, and Z. Yang. 2002. Accuracy and power of Bayes prediction of amino acid sites under positive selection. Mol. Biol. Evol. 19:950-958. - PubMed
- Bartholomew, J. S., S. N. Stacey, B. Coles, D. J. Burt, J. R. Arrand, and P. L. Stern. 1994. Identification of a naturally processed HLA A0201-restricted viral peptide from cells expressing human papillomavirus type 16 E6 oncoprotein. Eur. J. Immunol. 24:3175-3179. - PubMed
- Beckman, G., R. Birgander, A. Sjalander, N. Saha, P. A. Holmberg, A. Kivela, and L. Beckman. 1994. Is p53 polymorphism maintained by natural selection? Hum. Hered. 44:266-270. - PubMed
- Bernard, H. U., and D. Apt. 1994. Transcriptional control and cell type specificity of HPV gene expression. Arch. Dermatol. 130:210-215. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- CA85178/CA/NCI NIH HHS/United States
- CA78527/CA/NCI NIH HHS/United States
- R01 CA078527/CA/NCI NIH HHS/United States
- U01 CA078527/CA/NCI NIH HHS/United States
- R01 CA085178/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources